Postoperative management of Crohn disease

The Medical Clinics of North America
Su Min ChoMiguel Regueiro

Abstract

Crohn disease often recurs after surgical resection. Despite extensive research in the prevention of postoperative Crohn disease, optimal management strategies have yet to be defined. Risk of disease recurrence needs to be carefully balanced against potential risks associated with treatment. Patients with low risk of postoperative recurrence may not require medication, whereas those at moderate risk may benefit from antibiotics or immunomodulators. Those at highest risk of recurrence may benefit from biologic therapy for maintenance of surgical remission. Postoperative colonoscopy within 1 year of resective surgery is important for identification of disease recurrence and modification of medications.

References

Jan 24, 2002·Diseases of the Colon and Rectum·M Muñoz-JuárezM R Keighley
May 31, 2007·International Journal of Colorectal Disease·Marco ScarpaImerio Angriman
Dec 27, 2008·Gastroenterology·Miguel RegueiroScott E Plevy
Mar 27, 2009·Inflammatory Bowel Diseases·Miguel Regueiro

❮ Previous
Next ❯

Citations

Nov 26, 2015·The Surgical Clinics of North America·Panayiotis GrevenitisNilesh Lodhia
Oct 16, 2012·Expert Review of Gastroenterology & Hepatology·Jana G Hashash, Miguel D Regueiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Gastroenterology Clinics of North America
Su Min ChoMiguel Regueiro
© 2022 Meta ULC. All rights reserved